Skip to main content

Cadre Holdings, Inc.

CDRE
Exchange
NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001860543

In the last 90 days, Cadre Holdings, Inc. insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $952.8M in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $9.47M in total
2
13F holdersQ2 2026, −11 vs. previous quarter
156
13F valueReported value at the end of Q2 2026
$952.8M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding CDRE, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding CDRE at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Cadre Holdings, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 26, 2026 (view filing)4:15 PM ETAug 242 daysKanders Warren BCEO AND CHAIRMANSSaleCommon Stock, par value $0.0001 per share ("Common Stock")−65.4K$33.20−$2.17M−0.7%9.55M after
Aug 26, 2026 (view filing)4:15 PM ETAug 24-252 daysKanders Warren BCEO AND CHAIRMANSSale−134.6K$32.33−$4.35M−1.4%9.42M after3 lots
Aug 19, 2026 (view filing)4:15 PM ETAug 172 daysWilliams BradPRESIDENTSSale−88.7K$33.24−$2.95M−57.7%65.1K after2 lots
Jun 23, 2026 (view filing)Jun 185 daysKanders Warren BCEO AND CHAIRMANSSaleCommon Stock, par value $0.0001 per share ("Common Stock")−25.0K$27.86−$696.5K−0.3%9.67M after
Jun 23, 2026 (view filing)Jun 221 dayKanders Warren BCEO AND CHAIRMANSSale−50.0K$27.43−$1.37M−0.5%9.62M after
Jun 17, 2026 (view filing)Jun 152 daysKanders Warren BCEO AND CHAIRMANSSaleCommon Stock, par value $0.0001 per share ("Common Stock")−100.0K$30.03−$3.00M−1.0%9.82M after
Jun 17, 2026 (view filing)Jun 16-171 dayKanders Warren BCEO AND CHAIRMANSSale−125.0K$28.29−$3.54M−1.3%9.69M after2 lots
Mar 24, 2026 (view filing)Mar 204 daysKanders Warren BCEO AND CHAIRMANSSaleCommon Stock, par value $0.0001 per share ("Common Stock")−100.0K$31.40−$3.14M−1.0%10.0M after
Mar 24, 2026 (view filing)Mar 231 dayKanders Warren BCEO AND CHAIRMANSSale−100.0K$31.93−$3.19M−1.0%9.92M after
Dec 16, 2025 (view filing)Dec 124 daysBrowers BlaineCHIEF FINANCIAL OFFICERSSaleCommon Stock, par value $0.0001 per share ("Common Stock")−20.4K$43.79−$894.8K−24.5%63.1K after

Top 10 13F holders, Q2 2026

The largest institutional positions in Cadre Holdings, Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 156 holders
Institutions holding CDRE in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.2,936,878$83.7M0.00%+310,495+11.8%Added
Greenhouse Funds LLLP2,868,664$81.8M4.31%+2860.0%Added
Reinhart Partners, Inc.2,738,373$78.1M1.78%+500,476+22.4%Added
FMR LLC2,475,623$70.6M0.00%−843,573−25.4%Reduced
State Street Corp1,949,734$55.6M0.00%+553,411+39.6%Added
Capital International Investors1,622,466$46.3M0.01%+361,660+28.7%Added
Vanguard Capital Management LLC1,324,254$37.8M0.00%+76,805+6.2%Added
GW&K Investment Management, LLC1,274,371$36.3M0.28%+227,195+21.7%Added
Capital World Investors1,205,237$34.4M0.00%+32,880+2.8%Added
Wynnefield Capital Inc1,205,000$34.4M23.63%+55,000+4.8%Added